Bioremedy Pharma at CPHI Europe 2025
Bioremedy Pharma attended CPHI Europe 2025, advancing inbound licensing partnerships and expanding access to innovative healthcare products across Africa and the Middle East.
Press releases, partnership milestones and corporate updates from Bioremedy Pharma, a national Saudi healthcare company headquartered in Jeddah.
Stay informed on Bioremedy Pharma's latest milestones, partnerships and corporate developments.
A timeline of company developments. These milestones are not published news articles.
Bioremedy Pharma signed an agreement with Ekuberg Pharma (Italy) to license and register innovative products for the Saudi and regional markets.
Bioremedy Pharma expanded its nationwide distribution and cold chain network to widen access to its growing product portfolio across Saudi Arabia.
Bioremedy Pharma strengthened its neuropsychiatry portfolio through partnerships with Neuraxpharm, Invent Farma and Lesvi.
Bioremedy Pharma expanded into new therapeutic areas, broadening its offering across metabolic, women's health and wound care.
Meet the Bioremedy Pharma team at leading pharmaceutical and healthcare events across the region and beyond.
Browse our company milestones and events while we prepare new articles.
Try another category or view all published articles.
Bioremedy Pharma attended CPHI Europe 2025, advancing inbound licensing partnerships and expanding access to innovative healthcare products across Africa and the Middle East.